tetano
Editor, Senior Moderator
Microb Pathog
. 2025 Feb 20:107398.
doi: 10.1016/j.micpath.2025.107398. Online ahead of print. A detailed examination of Coronavirus disease 2019 (COVID-19): covering past and future perspectives
Sabina Yasmin[SUP] 1 [/SUP], Mohammad Yousuf Ansari[SUP] 2 [/SUP]
Affiliations
The COVID-19 disease has spread rapidly across the world within just six months, affecting 169 million people and causing 3.5 million deaths globally (2021). The most affected countries include the USA, Brazil, India, and several European countries such as the UK and Russia. Healthcare professionals face new challenges in finding better ways to manage patients and save lives. In this regard, more comprehensive research is needed, including genomic and proteomic studies, personalized medicines and the design of suitable treatments. However, finding novel molecular entities (NME) using a standard or de novo strategy to drug development is a time-consuming and costly process. Another alternate strategy is discovering new therapeutic uses for old/existing/available medications, known as drug repurposing. There are a variety of computational repurposing methodologies, and some of them have been used to counter the coronavirus disease pandemic of 2019 (COVID-19). This review article compiles recently published data on the origin, transmission, pathogenesis, diagnosis, and management of the coronavirus by drug repurposing and vaccine development approach. We have attempted to screen probable drugs in clinical trials by using literature survey. This systematic review aims to create priorities for future research of drugs repurposed and vaccine development for COVID-19.
Keywords: Diagnosis; Drug Repurposing; Pathogenesis; SARS-COV-2; Vaccine.
. 2025 Feb 20:107398.
doi: 10.1016/j.micpath.2025.107398. Online ahead of print. A detailed examination of Coronavirus disease 2019 (COVID-19): covering past and future perspectives
Sabina Yasmin[SUP] 1 [/SUP], Mohammad Yousuf Ansari[SUP] 2 [/SUP]
Affiliations
- PMID: 39986548
- DOI: 10.1016/j.micpath.2025.107398
The COVID-19 disease has spread rapidly across the world within just six months, affecting 169 million people and causing 3.5 million deaths globally (2021). The most affected countries include the USA, Brazil, India, and several European countries such as the UK and Russia. Healthcare professionals face new challenges in finding better ways to manage patients and save lives. In this regard, more comprehensive research is needed, including genomic and proteomic studies, personalized medicines and the design of suitable treatments. However, finding novel molecular entities (NME) using a standard or de novo strategy to drug development is a time-consuming and costly process. Another alternate strategy is discovering new therapeutic uses for old/existing/available medications, known as drug repurposing. There are a variety of computational repurposing methodologies, and some of them have been used to counter the coronavirus disease pandemic of 2019 (COVID-19). This review article compiles recently published data on the origin, transmission, pathogenesis, diagnosis, and management of the coronavirus by drug repurposing and vaccine development approach. We have attempted to screen probable drugs in clinical trials by using literature survey. This systematic review aims to create priorities for future research of drugs repurposed and vaccine development for COVID-19.
Keywords: Diagnosis; Drug Repurposing; Pathogenesis; SARS-COV-2; Vaccine.